Cargando…
Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
The lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of the biology and pathophysiology of cGvHD, as well as...
Autores principales: | Pusic, Iskra, Pavletic, Steven Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432377/ https://www.ncbi.nlm.nih.gov/pubmed/34595409 http://dx.doi.org/10.2991/chi.d.190314.001 |
Ejemplares similares
-
Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
por: Duraković, Nadira, et al.
Publicado: (2016) -
Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?
por: Pavletic, Steven Z., et al.
Publicado: (2022) -
Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016) -
Quantitative Salivary Proteomic Differences in Oral Chronic Graft-versus-Host Disease
por: Bassim, Carol W, et al.
Publicado: (2012) -
A starting point for the phenotypic classification of pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)